Pharma industry highly concerns about conflicts between medical and pharmaceutical associations over ‘Valsartan’

The pharmaceutical industry has shown high interests in recruiting the chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA).

In the circumstance where the antihypertensive ‘Valsartan’ case might extensively spread negative impacts, the industry has started to think that the management of the association will have more important roles.

First of all, the KPBMA ch...